Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study (vol 70, pg 526, 2009)

被引：0
|
作者：
Cutler, Andrew J.
机构：
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2009年 / 70卷 / 12期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：1729 / 1729
页数：1
相关论文
共 50 条
  • [31] Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy
    Weisler, Richard
    McIntyre, Roger S.
    Bauer, Michael
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (11) : 1183 - 1200
  • [32] Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder
    Bauer, Michael
    Dell'Osso, Liliana
    Kasper, Siegfried
    Pitchot, William
    Vansvik, Eva Dencker
    Koehler, Juergen
    Jorgensen, Leif
    Montgomery, Stuart A.
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 151 (01) : 209 - 219
  • [33] A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder
    Bauer, Michael
    El-Khalili, Nizar
    Datto, Catherine
    Szamosi, Johan
    Eriksson, Hans
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 127 (1-3) : 19 - 30
  • [34] Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
    Bandelow, Borwin
    Chouinard, Guy
    Bobes, Julio
    Ahokas, Antti
    Eggens, Ivan
    Liu, Sherry
    Eriksson, Hans
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (03): : 305 - 320
  • [35] Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder
    Vieta, Eduard
    Bauer, Michael
    Montgomery, Stuart
    McIntyre, Roger S.
    Szamosi, Johan
    Earley, Willie R.
    Eriksson, Hans
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 150 (02) : 639 - 643
  • [36] Extended release Quetiapine Fumarate (Quetiapine XR) in acute and maintenance studies in Major Depressive Disorder (MDD): suicidality data
    Weisler, R.
    Montgomery, S. A.
    Eriksson, H. A.
    Szamosi, J.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 45 - 46
  • [37] Efficacy of extended release quetiapine fumarate monotherapy in patients with generalised anxiety disorder : Results from 5 placebo-controlled trials
    Stein, D.
    Kalali, A.
    Bandelow, B.
    Katzman, M. A.
    Olausson, B.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 118 - 119
  • [38] Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial
    Katzman, Martin A.
    Brawman-Mintzer, Olga
    Reyes, Efren B.
    Olausson, Bengt
    Liu, Sherry
    Eriksson, Hans
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (01) : 11 - 24
  • [39] Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies (vol 16, pg 1733, 2013)
    Madhukar, H. T.
    Bandelow, B.
    Demyttenaere, K.
    Papakosta, George I.
    Szamosi, J.
    Earley, W.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (02):
  • [40] Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies (vol 16, pg 1733, 2013)
    Madhukar, H. T.
    Bandelow, B.
    Demyttenaere, K.
    Papakostas, G., I
    Szamosi, J.
    Earley, W.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (09):
12345